Droxidopa Capsule
Product Images NDC 63304-112

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Droxidopa (NDC 63304-112). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-droxidopa-200mglabel (Spl Droxidopa 200mglabel)

FDA Label Image

Spl-droxidopa-300mglabel (Spl Droxidopa 300mglabel)

Spl-droxidopa-300mglabel (Spl Droxidopa 300mglabel)
The text seems to be a label of a medication called "roxidopa" produced by Sun Pharmaceutical Industries. The label contains some dosage information and some cautionary statements ("Rx only" and "contains... yellow tartrazine"). Additional information such as usage and potential side effects may not be provided in this text.*
FDA Label Image

Spl-droxidopa-capsules-figure1 (Spl Droxidopa Capsules Figure1)

FDA Label Image

Spl-droxidopa-capsules-figure2 (Spl Droxidopa Capsules Figure2)

FDA Label Image

Spl-droxidopa-capsules-structure (Spl Droxidopa Capsules Structure)

FDA Label Image

Spl-droxidopa-label100mg (Spl Droxidopa Label100mg)

Spl-droxidopa-label100mg (Spl Droxidopa Label100mg)
Not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.